2m 2m 2m 2m 2m 2m 2m
SANARA MEDTECH (SMTI)
NASDAQ
$20.96-$0.31 (-1.43%)
Price as of Jun 03, 2026 4:10 PM EDT- $208.8MMarket Cap
- -27.12%1-Year Change
- Medical Instruments & SuppliesIndustry
SANARA MEDTECH (SMTI)
$20.96-$0.31 (-1.43%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 103.1M +18.97% | 86.7M +33.36% | 65.0M +41.77% | 45.8M +89.87% | |
Cost of Revenue | 7.5M -7.60% | 8.1M +3.66% | 7.9M +23.45% | 6.4M +175.22% | |
Gross Profit | 95.6M +1,274.42% | -8.1M -114.25% | 57.1M +44.72% | 39.5M +80.84% | |
Sales and Marketing Expense | 78.7M +2.82% | 76.6M +34.33% | 57.0M +23.97% | 46.0M N/A | |
Research and Development Expense | -5.1M -11.06% | -5.7M +38.01% | -4.1M +22.73% | -3.4M +502.65% | |
Depreciation and Amortization Expense | 3.9M -19.85% | 4.9M +33.96% | 3.7M +54.99% | 2.4M +297.18% | |
Total Operating Expenses | 88.3M +3.57% | 85.2M +38.95% | 61.4M +18.64% | 51.7M +77.05% | |
Operating Profit | 7.3M +208.77% | -6.7M +59.32% | -4.2M -65.54% | -12.2M +65.84% | |
Interest Income | 3,672 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -6.8M N/A | N/A N/A | -475,783 +67.09% | -284,746 +39,948.66% | |
Interest Income and Expense and Net | -6.8M N/A | 0 +100.00% | -475,783 +67.09% | -284,746 +39,948.66% | |
Total Nonoperating Income and Expense | -7.7M +140.82% | -3.2M +1,322.22% | -224,749 -86.82% | -1.7M +176.00% | |
Income before Taxes | 7.3M +208.77% | -6.7M +51.25% | -4.4M -68.14% | -13.9M +75.93% | |
Income Taxes | N/A N/A | -48,380 N/A | N/A N/A | -5.8M N/A | |
Extraordinary Items | 28.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -37.6M +288.66% | -9.7M +124.59% | -4.3M -45.79% | -7.9M -0.70% | |
Net Income from Continuing Operations Applicable to Common | -393,124 -95.93% | -9.7M +117.67% | -4.4M -68.14% | -13.9M +75.93% | |
Basic EPS and Net Income | -4.36 +282.46% | -1.14 +119.23% | -0.52 -48.00% | -1.00 -7.41% | |
Diluted EPS and Net Income | -4.36 +282.46% | -1.14 +119.23% | -0.52 -48.00% | -1.00 -7.41% | |
Basic Weighted Average Shares | 8.6M +1.64% | 8.5M +2.48% | 8.3M +4.71% | 7.9M +7.70% | |
Diluted Weighted Average Shares | 8.6M +1.64% | 8.5M +2.48% | 8.3M +4.71% | 7.9M +7.70% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 16.6M +4.41% | 15.9M +208.48% | 5.1M -42.55% | 9.0M -51.97% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 16.6M +4.41% | 15.9M +208.48% | 5.1M -42.55% | 9.0M -51.97% | |
Total Current Assets | 33.5M +0.71% | 33.3M +75.24% | 19.0M -7.81% | 20.6M -16.22% | |
Accumulated Depreciation | 672,872 +10.56% | 608,613 -49.12% | 1.2M +61.64% | 739,986 +116.01% | |
Property and Plant and Equipment and Net | 456,962 +5.70% | 432,317 -65.63% | 1.3M -11.19% | 1.4M -13.09% | |
Total Long-Term Assets | 39.4M -28.08% | 54.8M -0.14% | 54.9M +35.74% | 40.4M +242.88% | |
Total Assets | 72.9M -17.20% | 88.1M +19.25% | 73.9M +21.03% | 61.0M +67.70% | |
Income Taxes Payable | N/A N/A | N/A N/A | 1.0M 0.00% | 1.0M N/A | |
Total Short-Term Debt | 12.3M N/A | N/A N/A | 580,357 -76.79% | 2.5M 0.00% | |
Total Current Liabilities | 18.6M +21.82% | 15.3M +11.06% | 13.8M +7.51% | 12.8M +112.65% | |
Total Long-Term Debt | 46.5M +45.81% | 31.9M +188.61% | 11.1M N/A | N/A N/A | |
Total Long-Term Liabilities | 48.4M +42.78% | 33.9M +118.43% | 15.5M +138.36% | 6.5M +2,830.03% | |
Total Liabilities | 67.0M +36.26% | 49.2M +67.95% | 29.3M +51.61% | 19.3M +209.32% | |
Retained Earnings | -75.3M +99.30% | -37.8M +34.77% | -28.0M +19.84% | -23.4M +53.56% | |
Total Stockholders Equity | 5.9M -84.93% | 39.4M -12.11% | 44.8M +7.18% | 41.8M +36.51% | |
Total Shares Outstanding | 8.9M +2.21% | 8.8M +2.56% | 8.5M +2.83% | 8.3M +8.12% | |
Cash Flow | |||||
Cash from Operating Activities | 6.8M +28,634.43% | -23,784 -99.27% | -3.2M -41.57% | -5.6M +15.38% | |
Capital Expenditures | 4.6M +2,147.12% | 205,848 -22.39% | 265,246 +80.42% | 147,015 -14.46% | |
Cash from Investing Activities | -15.0M +126.48% | -6.6M -35.23% | -10.2M +190.67% | -3.5M -33.55% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.9M -48.82% | 17.4M +80.13% | 9.6M +1,636.81% | -627,346 -102.22% | |
Financials Ratio | |||||
Gross Margin | 92.71% +2.32% | 90.61% +3.06% | 87.92% +2.08% | 86.12% -4.76% | |
Operating Margin | 7.08% +191.42% | -7.75% +19.46% | -6.49% -75.69% | -26.68% -12.66% | |
Return on Assets | -46.65% +290.90% | -11.93% +87.07% | -6.38% -60.85% | -16.29% -52.89% | |
Return on Equity | -165.69% +622.05% | -22.95% +131.05% | -9.93% -54.66% | -21.91% -49.59% | |
Revenue Growth | 18.97% -43.13% | 33.36% -20.12% | 41.77% -53.53% | 89.87% +63.71% | |
Current Ratio | 1.80 -17.33% | 2.18 +57.79% | 1.38 -14.25% | 1.61 -60.60% | |
Cash Ratio | 0.89 -14.29% | 1.04 +177.75% | 0.37 -46.56% | 0.70 -77.41% | |
Debt-to-Equity Ratio | 9.90 N/A | N/A N/A | 0.26 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.81 N/A | N/A N/A | 0.16 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow